Woody Sherman

Company: Psivant Therapeutics

Job title: Chief Innovation Officer

Seminars:

AI/ML in Hit Identification – Exploring the Current State of the Field, Key Challenges, and Future Directions 1:10 pm

Artificial intelligence is widely regarded as the up and coming pathway in drug discovery, due to its potential to both accelerate and refine the hit identification process. AI offers novel avenues to hit ID to save time and ultimately costs through revolutionizing screening strategies by accurately  predicting suitable candidates and potential hits through a deep knowledge of…Read more

day: Pre-Conf Day